Angiotensin At1Receptor Signalling Pathways In Neurons
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
SUMMARY: 1. The aim of the present article is to review the intracellular signal transduction pathways that are influenced by the peptide angiotensin (Ang) II, acting via its type 1 (AT 1) receptor, in neurons. 2. The AT 1 receptors couple to a wide variety of signalling pathways in peripheral tissues, such as kidney, heart and vascular smooth muscle. A similar diversity of signalling mechanisms exists for AT 1 receptors in neurons. 3. We outline the known neuronal AT 1 receptor signalling pathways as they relate to function. Pathways that couple activation of AT 1 receptors to short‐term changes in neuronal membrane ionic currents and firing rate will be reviewed. These are different from the pathways that elicit longer‐term changes in enzyme activity and gene expression and, ultimately, increases in noradrenaline synthesis. 4. Novel AT 1 receptor signalling pathways discovered through gene expression profiling and their potential functional significance have been discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
G-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
Synapsins as Regulators of Neurotransmitter Release
Hilfiker, S., Pieribone, V. A., Czernik, A. J., Kao, H.-T., Augustine, G. J., & Greengard, P. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0378 · Cited by 537
Cited by
Fleegal-DeMotta, M. A., Doghu, S., & Banks, W. A. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.158 · Cited by 180
“As stated earlier, classically, Ang II-mediated physiologic responses involve activation of the AT1 receptor, which leads to activation of PKC (Sumners et al, 2002).”
BackgroundInfluentialReactive oxygen species in the neuropathogenesis of hypertension
Peterson, J. R., Sharma, R. V., & Davisson, R. L. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0056-1 · Cited by 139
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Cosarderelioglu, C., Nidadavolu, L. S., George, C. J., Oh, E. S., Bennett, D. A., Walston, J. D., & Abadir, P. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.586314 · Cited by 134
“This effect can be reversed by losartan, an ARB (Sumners et al., 2002).”
BackgroundAngiotensin-II, the Brain, and Hypertension: An Update
Young, C. N., & Davisson, R. L. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.03624 · Cited by 123
Metadata
- Authors
- Sumners, C., Fleegal, M. A., & Zhu, M.
- Venue
- Clinical and Experimental Pharmacology and Physiology
- Publisher
- Wiley
- Published
- 2002-05
- Volume
- 29
- Issue
- 5-6
- Pages
- 483-490
- ISSN
- 0305-1870 (ISSN-L)
- 1440-1681
- OpenAlex
- W2054640522
- Cited by
- 94
- References
- 3
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin At1Receptor Signalling Pathways In Neurons. https://app.cochat.ai/papers/10.1046/j.1440-1681.2002.03660.x
- The paper
- Sumners, C., Fleegal, M. A., & Zhu, M. (2002). Angiotensin At1Receptor Signalling Pathways In Neurons. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1046/j.1440-1681.2002.03660.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.